Physician profile
Mitchell Broussard
NPI 1013904473
$5,929.56
in general payments reported to CMS, 2019-2025
18 companies · $1,358 in 2025
The $1,358 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,696 · 2020: $224 · 2021: $136 · 2022: $1,524 · 2023: $566 · 2024: $425 · 2025: $1,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,218 · Education: $99.99 · Entertainment: $32.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,217.53 |
| Education | $99.99 |
| Entertainment | $32.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $3,951.52 | 2019-2025 | Clariti Contact Lens, Biofinity Contact Lens, Myday Contact Lens |
| Glaukos Corporation | $288.80 | 2025 | Photrexa Viscous and Photrexa |
| Mallinckrodt Hospital Products INC. | $268.46 | 2024-2025 | Acthar |
| Alcon Vision LLC | $202.89 | 2021-2025 | Total30, Precision 1, Dailies Total1 |
| Tarsus Pharmaceuticals, INC. | $200.69 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $169.08 | 2023 | Tearcare System |
| Dompe US, INC. | $158.63 | 2024-2025 | Oxervate |
| Biotissue Holdings INC. | $148.85 | 2025 | |
| Allergan, INC. | $131.45 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $122.78 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $98.33 | 2019 | |
| Novartis Pharmaceuticals Corporation | $49.21 | 2019-2023 | |
| Optos, INC. | $32.08 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Abbvie INC. | $29.42 | 2024-2025 | |
| Oyster Point Pharma, INC. | $27.81 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $24.98 | 2023 | Infuse |
| Carl Zeiss Meditec, INC. | $13.10 | 2019 | |
| Sun Pharmaceutical Industries INC. | $11.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Broussard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.